Medical treatment of COVID-19 pneumonia and associated myocarditis may lead to the resolution of new-onset left bundle branch block.
Answers are grounded in this paper and cite their sources.
May support reversible LBBB in COVID-19 myocarditis with pneumonia therapy; hypothesis-generating case requiring prospective confirmation.
We present the case of a 67-year-old woman with novel coronavirus-infected pneumonia, who was subsequently diagnosed with coronavirus disease 2019 (COVID-19)-related myocarditis and left bundle branch block (LBBB). COVID-19-infected pneumonia treatment, such as oseltamivir, azithromycin, ceftriaxone, and ascorbic acid, may be related to the reduction of myocarditis lesion. Reduction in lesions' size may improve the conduction system; therefore, LBBB can also be resolved in the treatment of COVID-19-infected pneumonia.
No takes yet. Share an insight, caveat, or question.
Yıldız et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: